海辰药业(300584.SZ)拟对安庆汇辰增资2亿元并为其引入1.25亿元新投资

智通财经网10-11

智通财经APP讯，海辰药业(300584.SZ)公告，公司全资子公司安庆汇辰科技有限公司(“安庆汇辰”)拟进行增资扩股，新增注册资本3.25亿元，其中顾玉琴以货币形式认缴新增出资1850万元、钱德民以货币形式认缴新增出资1650万元、陆士平以货币形式认缴新增出资1500万元、蒋金元以货币形式认缴新增出资7500万元、公司以货币形式认缴新增出资2亿元。公司作为安庆汇辰的原股东放弃对1.25亿元新增...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2474051033?lang=zh_CN&edition=full","thumbnail":"https://img.zhitongcaijing.com/astock/13.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","is_english":false,"pubTime":"2024-10-11 15:58","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2474051033","market":"hk","top_or_hot":-1,"title":"海辰药业(300584.SZ)拟对安庆汇辰增资2亿元并为其引入1.25亿元新投资","media":"智通财经网","content":"<div>\n<p>智通财经APP讯，海辰药业(300584.SZ)公告，公司全资子公司安庆汇辰科技有限公司(“安庆汇辰”)拟进行增资扩股，新增注册资本3.25亿元，其中顾玉琴以货币形式认缴新增出资1850万元、钱德民以货币形式认缴新增出资1650万元、陆士平以货币形式认缴新增出资1500万元、蒋金元以货币形式认缴新增出资7500万元、公司以货币形式认缴新增出资2亿元。公司作为安庆汇辰的原股东放弃对1.25亿元新增...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1192795.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海辰药业(300584.SZ)拟对安庆汇辰增资2亿元并为其引入1.25亿元新投资</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海辰药业(300584.SZ)拟对安庆汇辰增资2亿元并为其引入1.25亿元新投资\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-11 15:58 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1192795.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，海辰药业(300584.SZ)公告，公司全资子公司安庆汇辰科技有限公司(“安庆汇辰”)拟进行增资扩股，新增注册资本3.25亿元，其中顾玉琴以货币形式认缴新增出资1850万元、钱德民以货币形式认缴新增出资1650万元、陆士平以货币形式认缴新增出资1500万元、蒋金元以货币形式认缴新增出资7500万元、公司以货币形式认缴新增出资2亿元。公司作为安庆汇辰的原股东放弃对1.25亿元新增...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1192795.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300584","symbol_name":"海辰药业","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1192795.html","article_id":"2474051033","we_media_id":null,"thumbnails":["https://img.zhitongcaijing.com/astock/13.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474051033","pubTimestamp":1728633507,"columns":[],"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"海辰药业(300584.SZ)公告，公司全资子公司安庆汇辰科技有限公司(“安庆汇辰...","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300584":"海辰药业","BK0239":"医药制造"},"translate_title":"Haichen Pharmaceutical (300584. SZ) plans to increase the capital of Anqing Huichen by 200 million yuan and introduce 125 million yuan in new investment","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300584":1},"content_text":"智通财经APP讯，海辰药业(300584.SZ)公告，公司全资子公司安庆汇辰科技有限公司(“安庆汇辰”)拟进行增资扩股，新增注册资本3.25亿元，其中顾玉琴以货币形式认缴新增出资1850万元、钱德民以货币形式认缴新增出资1650万元、陆士平以货币形式认缴新增出资1500万元、蒋金元以货币形式认缴新增出资7500万元、公司以货币形式认缴新增出资2亿元。公司作为安庆汇辰的原股东放弃对1.25亿元新增注册资本的优先认缴权。增资扩股完成后，公司对安庆汇辰的持股比例为75.00%。据悉，本次全资子公司安庆汇辰增资扩股引入新投资者有助于加速安庆汇辰产能建设，为经营提供资金，可促进安庆汇辰的长远可持续发展。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474051033"}